Trials / Terminated
TerminatedNCT03395353
A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
A Long-term Safety Study of Duloxetine Hydrochloride in the Treatment of Japanese Children and Adolescents With Depressive Disorder
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 151 (actual)
- Sponsor
- Shionogi · Industry
- Sex
- All
- Age
- 9 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this long-term study is to evaluate the safety and efficacy of duloxetine hydrochloride in Japanese children and adolescents with depressive disorder.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine Hydrochloride | Administered orally |
Timeline
- Start date
- 2018-01-29
- Primary completion
- 2020-07-04
- Completion
- 2020-07-04
- First posted
- 2018-01-10
- Last updated
- 2021-06-18
- Results posted
- 2021-06-18
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03395353. Inclusion in this directory is not an endorsement.